Mutation Hot Spots in 5q31-Linked Corneal Dystrophies  by Korvatska, E. et al.
Am. J. Hum. Genet. 62:320–324, 1998
320
Mutation Hot Spots in 5q31-Linked Corneal Dystrophies
E. Korvatska,1 F. L. Munier,1,3 A. Djemaı¨,1 M. X. Wang,4 B. Frueh,5 A. G.-Y. Chiou,6 S. Uffer,3
E. Ballestrazzi,6 R. E. Braunstein,7 R. K. Forster,8 W. W. Culbertson,8 H. Boman,9
L. Zografos,3 and D. F. Schorderet1,2
1Unit of Molecular Genetics and 2Division of Medical Genetics, Centre Hospitalier Universitaire Vaudois, and 3Department of
Ophthalmology, Hoˆpital Jules Gonin, Lausanne; 4Department of Ophthalmology, Vanderbilt University School of Medicine, Nashville;
5Augenklinik, Inselspital, Bern; 6Clinica Oculistica, L’Aquila, Italy; 7Edward S. Harkness Eye Institute, Columbia Presbyterian Medical Center,
New York; 8Bascom Palmer Eye Institute, Miami; and 9Department of Medical Genetics, Haukeland Hospital, University of Bergen, Bergen
Summary
Mutations in the BIGH3 gene on chromosome 5q31
cause four distinct autosomal dominant diseases of the
human cornea: granular (Groenouw type I), Reis-Bu¨ck-
lers, lattice type I, and Avellino corneal dystrophies. All
four diseases are characterized by both progressive ac-
cumulation of corneal deposits and eventual loss of vi-
sion. We have identified a specific recurrent missense
mutation for each type of dystrophy, in 10 independently
ascertained families. Genotype analysis with microsat-
ellite markers surrounding the BIGH3 locus was per-
formed in these 10 families and in 5 families reported
previously. The affected haplotype could be determined
in 10 of the 15 families and was different in each family.
These data indicate that R555W, R124C, and R124H
mutations occurred independently in several ethnic
groups and that these mutations do not reflect a putative
founder effect. Furthermore, this study confirms the spe-
cific importance of the R124 and R555 amino acids in
the pathogenesis of autosomal dominant corneal dys-
trophies linked to 5q.
Introduction
Granular (Groenouw type I [CDGG1]; OMIM 121900
[http://www3.ncbi.nlm.nih.gov:80/htbin-post/Omim/
dispmim?121900]), lattice type I (CDL1; OMIM
122200 [http://www3.ncbi.nlm.nih.gov:80/htbin-post/
Omim/dispmim?122200]), Avellino (ACD) and Reis-
Bu¨cklers (CDRB; OMIM 121900 [http://www3.ncbi
.nlm.nih.gov:80/htbin-post/Omim/dispmim?121900])
corneal dystrophies are bilaterally symmetrical disorders
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that are inherited in an autosomal dominant pattern and
are characterized by progressive accumulation of corneal
deposits that begin to appear during the 1st or 2d decade
of life. With time, these opacities cause serious visual
handicaps, often requiring phototherapeutic keratec-
tomy or corneal transplantation (Ridgway and Møller
1992; Rogers et al. 1993). Histopathologically, CDGG1
displays an accumulation of discrete granular opacities,
starting in the anterior third of the cornea. The clinical
and histological characteristics of CDGG1 and CDRB
overlap considerably. However, CDRB can be distin-
guished by an earlier onset, painful recurrent erosions,
and more superficially localized corneal opacities (Ku¨-
chle et al. 1995). In the case of CDL1, also classified as
single-organ amyloidosis, the branching linear amyloid
deposits are localized in the central part of the cornea
(Klintworth 1967). ACD, a mixed type, presents both
CDGG1- and CDL1-like clinical features (Folberg et al.
1988).
We recently reported four missense mutations in the
BIGH3 gene, encoding the kerato-epithelin (KE) pro-
tein. Each form of 5q31-linked autosomal dominant cor-
neal dystrophy was associated with a different mutation:
CDL1 with R124C, ACD with R124H, CDGG1 with
R555W, and CDRB with R555Q (Munier et al. 1997).
To better define the genotype-phenotype correlations
and to determine whether mutations inBIGH3 are solely
responsible for 5q31-linked autosomal dominant cor-
neal dystrophies, we screened 10 additional families af-
fected with CDGG1, CDL1, or ACD, and we observed
that the mutations reported previously occurred in all
10 families. Haplotype analysis revealed that these mu-
tations have arisen independently several times and that
they do not originate from a common founder. There-
fore, CpG dinucleotides at amino acids R124 and R555
represent hot spots for mutations in the 5q31-linked
corneal dystrophies.
Patients, Material, and Methods
Patients
Blood samples were obtained after informed consent
from individuals diagnosed with 5q31-linked corneal
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Table 1
Haplotype Analysis among Families with Corneal Dystrophy
HAPLOTYPE IN FAMILY
MARKER
A. CDGG1
G-1a G-2 G-3 G-4 G-5
R555W     
D5S393 8 10 4 6 (3 7)
D5S399 3 7 1 8 (9 1)
D5S500 6 9 6 10 (1 6)
D5S396 3 2 2 2 (5 2)
B. CDL1
L-1a L-2a L-3 L-4 L-5 L-6
R124C      
D5S393 4 4 4 (4 3) (4 4) 3
D5S399 9 4 5 (9 3) (5 12) 3
D5S500 8 6 4 (8 4) (6 8) 4
D5S396 2 3 4 (2 2) (3 5) 3
C. ACD
A-1a,b A-2a,b A-3 A-4
R124H    
D5S393 5 (5 3) (4 8) 4
D5S399 9 (9 4) (4 4) 4
D5S500 8 (8 4) (6 9) 6
D5S396 4 (2 2) (2 2) 5
NOTE.—Affected haplotype is given; where not determined, both alleles are given in parentheses.
a Mutations from these families were reported previously.
b No histology available.
dystrophies. These individuals were members of 10 dif-
ferent families. All diagnoses were confirmed histologi-
cally after corneal transplantation in at least one affected
family member, with the exception of two patients with
ACD (see table 1). One of the non–histologically doc-
umented cases of ACD was in a patient from Avellino,
Italy, and the other was in a patient from France. More
than 100 Caucasians participated as control individuals
for mutation search. DNA extraction from peripheral
blood was performed according to standard protocols.
Haplotyping
Haplotypes were constructed by use of a minimum-
recombination strategy in 15 families (including 5 fam-
ilies reported elsewhere [Munier et al. 1997]). Micro-
satellite analysis was performed with fluorescent-labeled
primers by use of a standard semiautomated method on
an automated laser fluorescent (ALF) DNA sequencer
(Pharmacia Biotech), as described elsewhere (Korvatska
et al. 1996).
Screening of Mutations
All exons of the BIGH3 gene were analyzed by means
of SSCP, as described elsewhere (Munier et al. 1997).
To screen the intron portions flanking exon 12, we used
two new primers for this region: BIGexon12-2F (5′-CA-
TTCCAGTGGCCTGGACTCTACTATC-3′) and BIG-
exon12-2R (5′-GGGGCCCTGAGGGATCACTACTT-
3′).
Sequencing
PCR amplicons showing abnormal migrating patterns
on SSCP were subcloned and sequenced with the
AutoRead sequencing kit (Pharmacia Biotech), on both
strands, by use of vector and internal primers. Sequenc-
ing products were resolved on an ALF DNA sequencer.
To control for PCR-induced errors, we sequenced at least
10 independent clones in the region of each mutation/
polymorphism.
Genomic DNA amplification of exons 4 and 12 was
performed by use of the corresponding forward and re-
verse primers. PCR products were reamplified with a
fluorescent nested primer (exon 4: 5′-GAGGCC-
ATCCCTCCTTCTGT-3′; exon 12: 5′-CCAGTGGCC-
TGGACTCTACTATCCTCA-3′) and were sequenced di-
rectly with the Thermo Sequenase fluorescent-labeled
primer cycle-sequencing kit (Amersham Life Science).
Samples were resolved on an ALF DNA sequencer. The
mutations were deposited in GenBank (accession
numbers AF035626, AF035627, AF035628, and
AF035629).
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Table 2
Mutation Analysis in 16 Families with 5q31-Linked Corneal
Dystrophies
Mutation
Corneal Dystrophy
Type
No. of Families
with Mutation/Total
No. of Families
R124:
R124C CDL1 6/6
R124H ACD 4/4
R555:
R555W CDGG1 5/5
R555Q CDRB 1/1
Table 3
Variants or Polymorphisms in BIGH3
LOCATION
VARIANT OR
POLYMORPHISM
CONFIRMATION
METHOD
NO. OF CHRO-
MOSOMES
TESTED
FREQUENCY
IN CON-
TROL POPU-
LATION (%)Nucleotide Codon
Exon 4 294A/T P98P Sequencing 24 100
Exon 4 405C/T P135P ApaI digestion 200 0
Intron 4 IVS416CrT . . . Sequencing 100 10
Exon 7 852C/A A284A StuI digestion 200 0
Exon 8 981A/G V327V Sequencing 50 18
Exon 11 1416C/T L472L Sequencing 50 18
Exon 12 1620T/C F540F Sequencing 50 25
Intron 12 IVS1223ArG . . . Sequencing 50 66
Results
Mutation Screening
DNA samples from 10 probands of various ethnic
origins (American, French, Italian, Vietnamese, German,
Austrian, and Norwegian) affected with CDGG1 (4 fam-
ilies), CDL1 (4 families), or ACD (2 families) were
screened for mutations within the complete coding re-
gion of BIGH3 (table 1). Initially, we searched, by direct
sequencing of exons 4 and 12, for the four previously
described mutations: R124C, R124H, R555Q, and
R555W. We then analyzed BIGH3 exons, including in-
tron boundaries, by means of SSCP, as described else-
where (Munier et al. 1997).
Table 1 summarizes the data for 15 families, including
the 5 families reported elsewhere (Munier et al. 1997).
We observed the presence of the R555W mutation in all
five families with CDGG1, the R124H mutation in all
four families with ACD, and the R124C mutation in all
six families with CDL1. When pooled, these data indi-
cate that recurrent mutations at CpG dinucleotides of
R124 and R555 are responsible for the 5q31-linked cor-
neal dystrophies in all 16 families, including the CDRB
family reported elsewhere (table 2; Munier et al. 1997).
Haplotype Analysis
To test the hypothesis of a common ancestor versus
multiple independent occurrences of an identical mu-
tation in each 5q31-linked corneal dystrophy, we deter-
mined the affected haplotype by genotyping the available
family members by use of four microsatellite markers
within 1 cM of the disease locus (Korvatska et al. 1996).
For five families, we received DNA from only one af-
fected member; therefore, we were unable to determine
the affected haplotype. According to our data (table 1),
families with recurring mutations could be related in
only four cases: L-1 and L-4 (possible common haplo-
type over the 1-cM region analyzed); G-3 and G-5 (pos-
sible shared fragment D5S399-D5S500-D5S396); and
A-1 and A-2, as well as A-3 and A-4 (possible shared
fragment D5S393-D5S399-D5S500). Not surprisingly,
cases in which the haplotypes could be identical were in
families whose affected haplotypes have not been
determined.
Identification of Variants or Polymorphisms
Probands from families with 5q31-linked corneal dys-
trophies, as well as patients with other forms of corneal
dystrophy, were screened for mutations in the BIGH3
exons, by means of SSCP analysis. Electrophoretic-mo-
bility shifts were detected in some probands and/or in
control individuals, for exons 4, 7, 8, 11, and 12 and
for introns 4 and 12. PCR products demonstrating bands
that, relative to wild type, were aberrantly migrating,
were sequenced. We identified a total of eight different
nucleotide changes. These alterations were classified as
polymorphisms because they do not change the amino
acid sequence of the protein, they do not cosegregate
with the disease, and all but two of them are present in
normal control individuals (table 3). The P135P and
A284A variants were observed in only one individual
each.
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Discussion
We recently established that CDGG1, CDL1, ACD,
and CDRB—four clinically distinct 5q31-linked auto-
somal dominant corneal dystrophies—are caused by al-
lelic mutations of BIGH3. Four missense mutations were
observed at two amino acid positions. Occurrence of
identical mutations in two families with CDL1 and in
two families with ACD could be explained by an un-
known—and possibly very remote—relationship, by the
presence of two hot spots, or by chance. It is therefore
important to establish whether 5q31-linked corneal dys-
trophies are due to numerous different alterations in
BIGH3 or to preferential mutations. To gain insight into
the molecular basis of these corneal dystrophies, in the
present study, we searched for mutations in 10 addi-
tional families. We established the affected haplotypes
in 6 of the 10 additional families and in 4 of the 5
families reported elsewhere.
All five CDGG1 families shared the R555W mutation.
In four families, the affected haplotypes could be estab-
lished, and all four were different (table 1). Although
the affected haplotype for G-5 cannot be individualized,
since we obtained DNA from only one affected family
member, it appears to be different. The four ACD
R124H-positive families, from Italy, France, Austria,
and Germany, showed at least two different genetic or-
igins. Haplotype analysis in six CDL1 R124C-positive
families from three different ethnic groups (three Swiss,
one French, and two American) showed that recurrent
mutations have occurred in at least five families.
In our collection of 16 families, including 6 reported
elsewhere, there have been perfect correlations between
CDGG1 and R555W, between ACD and R124H, and
between CDL1 and R124C. We have analyzed only one
CDRB family (mutation R555Q); therefore, no com-
ment on the prevalence of the R555Q mutation can be
made. However, it is evident that independent mutations
have occurred on numerous occasions at both the R124
and R555 codons and that these mutations clearly are
not due to a founder effect.
Observing independent mutations at two amino acid
positions, as opposed to establishing a founder effect,
has important implications for the molecular diagnosis
and for the understanding of the pathophysiology of the
5q31-linked corneal dystrophies. It is interesting to note
that both amyloid-related phenotypes (CDL1 and ACD)
involve R124 mutations and that both nonamyloid-re-
lated phenotypes (CDGG1 and CDRB) involve R555
mutations. How R124- and R555-mutated KE results
in the accumulation of corneal deposits is not yet clear;
analysis of additional families with 5q31-linked corneal
dystrophies will be necessary to establish the true prev-
alence of the R124 and R555 mutations and to deter-
mine whether mutations at other amino acids also lead
to amyloid or nonamyloid deposits.
Two hypotheses might explain the pathogenesis of the
deposits. On one hand, the phenotype could be due to
an aberrant function resulting from a specific alteration
of KE by the R124 and R555 mutations. R555 is located
in a predicted coiled-coil domain, and its mutation could
lead to a modification of this domain. This, in turn,
could impair binding to stromal proteins such as col-
lagen VI, for example (Hirano et al 1996). R124C and
R124H abolish a putative phosphorylation site; thus,
they could have important consequences on the structure
of KE. On the other hand, degradation of the mutated
KE could be disturbed by these mutations, and either
an amyloidogenic part of the protein (in the case of
CDL1 and ACD, since this has been reported for many
amyloidoses) or the complete protein (in the case of
CDGG1 and CDRB) could aggregate to form the corneal
deposits.
In summary, we have presented data indicating that
5q31-linked corneal dystrophies are due to recurrent in-
dependent mutations at two specific codons of BIGH3
and that, so far, the phenotype is perfectly correlated
with these mutations: R124C (in the case of CDL1),
R124H (in the case of ACD), and R555W (in the case
of CDGG1).
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